Mitsugu Sekimoto

Kansai Medical University

Japan

Research Interests

Explore related searches

Professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (13)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2020

Collaborators (7)

Nobuhiro Shibata

Lecturer

Kansai Medical University

JAPAN

View details

Sohei Satoi

Kansai Medical University

JAPAN

View details

Hisashi Kosaka

Kansai Medical University

JAPAN

View details

Tomohisa Yamamoto

Kansai Medical University

JAPAN

View details

Shogen Boku

Lecturer

Osaka University Hospital

JAPAN

View details

Masaki Kaibori

Professor

Kansai Medical University

JAPAN

View details

Daisuke Hashimoto

Kansai Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mitsugu Sekimoto

Research Interests

Explore related searches

Contact this professor

Articles (13)

Reconsideration of the clinical impact of neoadjuvant therapy in resectable and borderline resectable pancreatic cancer: A dual-institution collaborative clinical study

Hepatoprotection of a Standardized Extract of Cultured Lentinula edodes Mycelia against Liver Injury Induced by Ischemia-Reperfusion and Partial Hepatectomy

Sulforaphane Is Protective against Warm Ischemia/Reperfusion Injury and Partial Hepatectomy in Rats

The Prognostic Impact of ABO Blood Group in Hepatocellular Carcinoma Following Hepatectomy

Preoperative Serum Markers and Risk Classification in Intrahepatic Cholangiocarcinoma: A Multicenter Retrospective Study

Modified Albumin-Bilirubin Grade and Alpha-Fetoprotein Score (mALF Score) for Predicting the Prognosis of Hepatocellular Carcinoma after Hepatectomy

Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan

Predicting Complications following Surgical Resection of Hepatocellular Carcinoma Using Newly Developed Neo-Glasgow Prognostic Score with ALBI Grade: Comparison of Open and Laparoscopic Surgery Cases

Long-term outcomes of patients with multifocal intraductal papillary mucinous neoplasm following pancreatectomy

Intraperitoneal Paclitaxel Treatment for Patients with Pancreatic Ductal Adenocarcinoma with Peritoneal Dissemination Provides a Survival Benefit

Role of Substance P–Dependent Chemotactic Signaling in Postoperative Adhesion Formation

Perioperative Geriatric Assessment as A Predictor of Long-Term Hepatectomy Outcomes in Elderly Patients with Hepatocellular Carcinoma

Benefits of Conversion Surgery after Multimodal Treatment for Unresectable Pancreatic Ductal Adenocarcinoma

Collaborators (7)

Nobuhiro Shibata

Sohei Satoi

Hisashi Kosaka

Tomohisa Yamamoto

Shogen Boku

Masaki Kaibori

Daisuke Hashimoto

Make your next move.